期刊文献+

预防输血相关性移植物抗宿主病发生的研究进展 被引量:7

Progress in the Prevention of Transfusion-associated Graft-versus-host Disease
下载PDF
导出
摘要 输血是医疗救治的重要手段,但同时存在着多种并发症。输血相关性移植物抗宿主病(TA-GVHD)是其中之一,该病发生率为0.5%左右,死亡率却超过90%。由于TA-GVHD一旦发生,可逆转和治愈的几率低,所以TA-GVHD的预防显得尤为重要[1]。目前,预防TA-GVHD的主要方法有三种,一是利用白细胞过滤器进行去除白细胞后的输血[2];二是伽马血液辐照仪对血液制品进行伽马辐照,使血液制品中的T淋巴细胞失活,从而不再攻击人体[3];三是通过修改核酸,干扰病原体和白细胞的复制,抑制T淋巴细胞增殖。本文针对输血过程中可能发生的TA-GVHD,阐述了其发病机制、临床表现,着重探讨了目前预防TA-GVHD发生的三种方法,以期为减少TA-GVHD的发生提供参考。 Transfusion is an important means for medical treatment, but it has many syndromes such as transfusion- associated Graft- versus- host disease, its occurrence rate of 5‰ and above 90% death rate. Because of the difficulty in reversing TA-GVHD responses once they have been initiated, focus was placed on identifying approaches capable of preventing the onset of TA-GVHD. Nowadays, there are mainly three methods including leukocyte filter, gamma blood irradiator and pathogen inactivation to prevent TA-GVHD. This paper will summarize the clinical picture and treatment of TA-GVHD, and focus on the introduction of three prevention methods.
作者 叶立文
出处 《标记免疫分析与临床》 CAS 2015年第12期1297-1299,共3页 Labeled Immunoassays and Clinical Medicine
关键词 TA-GVHD 预防 白细胞过滤器 血液辐照 修改核酸 TA- GVHD Prevention Leukocyte filter Blood irradiation Nucleic acid modification
  • 相关文献

参考文献14

  • 1Dwyre D M, Holland P V. Transfusion- associatedgraft- versus- host disease. Vox Sang,2008,95(2) : 85-93.
  • 2Akahoshi M, Takanash M, Masuda M, et al. A case of -versus-host disease not prevemedby white cell- reduction filters. Transfusion, 1992,32 (2) : 169-172.
  • 3Benjamin'R J, Mccullough J, Mintz P D, et al. Therapeutic efficacy and safety of redblood cells treated with a chemical process( S-303 ) for pathogen inactivation: a Phase IIIdinical trial in cardiac surgery patients. Transfusion,2005,45( 11 ) : 1739-1749.
  • 4金明珠,刘凤华.血液辐照预防输血相关性移植物抗宿主病的发生[J].临床血液学杂志(输血与检验),2008,21(1):104-106. 被引量:7
  • 5周祺芳,王红梅,邵宗鸿.输血相关的移植物抗宿主病[J].临床输血与检验,2004,6(3):238-240. 被引量:6
  • 6Juji T, Takahashi K, Shibata Y, et al. Post-transfusion graft- versus-host disease in immunocompetent patients after cardiac surgery in Japan. N Engl J Med, 1989,321 ( 1 ) : 56.
  • 7Solheim B G. Pathogen reduction of bloodcomponents. Transfus Apher Sci ,2008,39( 1 ) :75-82.
  • 8Sehooneman F. Extracorporeal photophersis technical aspects. Transfus Aphersis Sci, 2003, 28(1 ) :51-61.
  • 9Anderson K C, Weinstein H J, Transfusion-associated graft-versus- host disease. New Engl J Med, 1990,323(19) :315-321.
  • 10Rahn R O. Chemical dosimetry using an iodide/iodate aqueous solution : application to the gamma irradiation of blood. Appl Radiat Isot, 2003,58( 1 ) :79-84.

二级参考文献32

  • 1周祺芳,王红梅,邵宗鸿.输血相关的移植物抗宿主病[J].临床输血与检验,2004,6(3):238-240. 被引量:6
  • 2王毅力,邓秀芝,高健.输血相关性移植物抗宿主病的研究进展[J].现代诊断与治疗,2005,16(1):34-37. 被引量:7
  • 3孙自敏,吴竞生,王祖贻.脐带血造血干细胞移植[J].临床输血与检验,1999,1(1):58-60. 被引量:1
  • 4刘凤华.警惕输血相关性移植物抗宿主病的发生[J].中国急救医学,2006,26(11):849-850. 被引量:3
  • 5罗春华,孔珮艳.输血相关性移植物抗宿主病[J].国外医学(输血及血液学分册),1996,19(5):295-298. 被引量:7
  • 6Vander BJ,Vanden MA,Drabbels JJ,et al.Transfusion-associated graft vs.host disease after donor-soecific leukocyte transfusion before kidney transplantation[J].Clin Transplant,2003,17(5):477-483.
  • 7Brubaker DB.Immunopathogenic mechanism of post transfusion graft-versus-host disease[J].Proc Soc Exp Biol Med,1993,202(2):122-125.
  • 8Petz LD,Calboun L,Yam P,et al.Transfusion-associated graft-versus-host disease in immunocompetent patients:report of a fatal case associated with transfusion of blood from a second-degree relative and a survey of predisposing factors[J].Transfusion,1993,33(8):742-744.
  • 9Hathaway WF,Githens JA,Blackburn JR,et al.N Engl J Med,1965,273:953.
  • 10Ahya R,Douglas JG,Waston HG.Transfusion associated graft versus host disease in an immunocompetent individual following coronary artery bypass grafting[J].Heart,1999,80(3):299-300.

共引文献11

同被引文献53

引证文献7

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部